In Silico Drug Repurposing to Inhibit SARS-CoV-2 Protease
Anne Goupil-LamyStay up to date
Receive monthly updates on content you won’t want to miss
- Brands
- Industries
- All industries
- Aerospace & Defense
- Architecture, Engineering & Construction
- Business Services
- Cities & Public Services
- Consumer Packaged Goods & Retail
- High-Tech
- Home & Lifestyle
- Industrial Equipment
- Infrastructure, Energy & Materials
- Life Sciences & Healthcare
- Marine & Offshore
- Transportation & Mobility
- Topics
Anne Goupil-LamySubscribe
Register here to receive updates featuring our newest content.